Search Count: 32
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2025-02-12 Classification: IMMUNE SYSTEM Ligands: PEU, IPA |
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Compound 18
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-05-15 Classification: HYDROLASE Ligands: PBP, H2S, DMS, GOL |
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Compound 32
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2024-05-15 Classification: HYDROLASE Ligands: A8J, GOL, H2S, DMS |
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Compound 52
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2024-05-15 Classification: HYDROLASE Ligands: AIE, H2S |
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Compound 55
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2024-05-15 Classification: HYDROLASE Ligands: AJF, DMS, H2S |
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Compound 58
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2024-05-15 Classification: HYDROLASE Ligands: AO0, GOL, DMS |
 |
The Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Compound 65
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-05-15 Classification: HYDROLASE Ligands: B7Y, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2023-08-02 Classification: IMMUNE SYSTEM Ligands: P15 |
 |
High Resolution Crystal Structure Of Glyceraldehyde-3-Phosphate Dehydrogenase From Candida Albicans Complexed With Nad+
Organism: Candida albicans sc5314
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2023-06-07 Classification: OXIDOREDUCTASE Ligands: NAD, EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2019-11-06 Classification: HYDROLASE/HYDROLASE Inhibitor Ligands: 063 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2019-11-06 Classification: HYDROLASE Ligands: PV7 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2019-11-06 Classification: HYDROLASE Ligands: EDO, PUV |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2019-11-06 Classification: HYDROLASE/Immune System Ligands: PVM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2019-11-06 Classification: HYDROLASE/Immune System Ligands: PVJ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.64 Å Release Date: 2019-11-06 Classification: HYDROLASE Ligands: PVV |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: WOE |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU5 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU3 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU7, PO4 |
 |
Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2010-09-15 Classification: TRANSFERASE Ligands: VGH |